Evidence map›Paper›PMID 30706223›Full record

ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2019

Iron oxide nanoparticulate system as a cornerstone in the effective delivery of Tc-99 m radionuclide: a potential molecular imaging probe for tumor diagnosis.

Mohamed M Swidan, Omnya M Khowessah, Mohamed Abd El-Motaleb, Ahmed Abd El-Bary, Mohamed T El-Kolaly, Tamer M Sakr

Open access · bronzeAbstract read
In one paragraph

Article in Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 26 citations in OpenAlex.

  1. Development ofDiscover nano · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mohamed M SwidanLabeled Compounds Department, Hot Labs Center, Egyptian Atomic Energy Authority, PO13759, Cairo, Egypt. dr_swidan@yahoo.com.ORCID http://orcid.org/0000-0002-1642-3775
Omnya M KhowessahPharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Cairo University, PO11562, Cairo, Egypt.
Mohamed Abd El-MotalebLabeled Compounds Department, Hot Labs Center, Egyptian Atomic Energy Authority, PO13759, Cairo, Egypt.
Ahmed Abd El-BaryPharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Cairo University, PO11562, Cairo, Egypt.
Mohamed T El-KolalyLabeled Compounds Department, Hot Labs Center, Egyptian Atomic Energy Authority, PO13759, Cairo, Egypt.
Tamer M SakrRadioactive Isotopes and Generator Department, Hot Labs Center, Egyptian Atomic Energy Authority, PO13759, Cairo, Egypt. Tamer_sakr78@yahoo.com.
Egyptian Atomic Energy Authority · EGCairo University · EG

Funding

International Atomic Energy Agency F22064
6 · The paper itself

Abstract

backgroundThe evolution of nanoparticles has gained prominence as platforms for developing diagnostic and/or therapeutic radiotracers. This study aims to develop a novel technique for fabricating a tumor diagnostic probe based on iron oxide nanoparticles excluding the utilization of chelating ligands.

methodsTc-99 m radionuclide was loaded into magnetic iron oxide nanoparticles platform (MIONPs) by sonication.

results

conclusionStabilized encapsulation of

Indexed as

Administration, IntravenousAnimalsCell LineCell SurvivalFerric CompoundsHumansMagnetite NanoparticlesMiceNeoplasm TransplantationParticle SizeTechnetiumFerric Compoundsferric oxideMagnetite NanoparticlesTechnetiumTechnetium-99Chelator free radiolabelingEncapsulationMagnetic iron oxide nanoparticlesTc-99 m radionuclideTumor deliveryTumor diagnosis

Identifiers

PMID30706223
PMCPMC6593133
OpenAlexW2913664480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.